Skip to main content
. Author manuscript; available in PMC: 2008 Apr 30.
Published in final edited form as: J Neuroimmunol. 2007 Apr 10;186(1-2):27–36. doi: 10.1016/j.jneuroim.2007.02.007

Table 1.

Types of adrenergic receptors expressed by hematopoietic progenitors shown as MFI

Hematopoietic Progenitors α1- AR# α1- AR+ Blocking peptide# Mean Fold Difference α2- AR# α2- AR+ Blocking peptide# Mean Fold Difference β2- AR# β2- AR+ Blocking peptide Mean Fold Difference
ER-MP-20+ 5,094±194 2,088±40 2.44 10,431±809 4,804±96 2.17 28,254±1,805 8,542±870 3.31
ER-MP-12+ 1,477±47 756±13 1.95 7,745±155 3,769±120 2.05 11,120±987 4,356±67 2.55
CD34+ 1,645±38 908±25 1.81 7,654±167 3,356±87 2.28 4,648±99 1,644±49 2.83
CD117+ 1,542±29 739±16 2.09 1,389±46 817±34 1.70 5,908±128 2,104±32 2.81
#

MFI (mean fluorescent intensity) expressed as Mean±SEM. Approximately a two-fold difference in MFI of the bound specific primary antibodies in the presence and absence of competing blocking peptides signifies the specificity of the α1-, α2- and β2- adrenergic receptor antibodies.